Zacks1d agobullish
RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance RaisedRadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
312last 24h
2132last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
Zacks6d agobullish
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance RaisedMcKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.
Zacks12d agobullish
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance RaisedMerit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.
StockStory20d agobullish
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock SoarsHealthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.
Zacks68d agobullish
COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance TrimmedCooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.